In order to serve its customers in an effective way and offer them all new services, Pharmacyte Biotech Inc (OTCMKTS:PMCB) has decided to come up with a new corporate website. Pharmacyte is a clinical stage biotechnology, which is known for developing targeted treatments for diabetes and cancer.
Insights On The Matter:
There are not many firms in this world that try to develop cancer treatment using live-cell encapsulation technology, Pharmacyte seems to be an exception among them. It uses world-class live-cell encapsulation technology named Cell-in-a-Box to cure diabetes as well as cancer. The company has been trying to establish itself as a brand in the pharmaceutical industry for a long time, and the decision of launching a revamped website is the first stepping stone in that direction. Management of Pharmacyte wants to transform the company into a separate biotechnology firm.
The company has changed its ticker symbol as well as the name in order to reveal its growth plans. It’s because of the recent aggressive steps taken by Pharmacyte Biotech Inc (OTCMKTS:PMCB), the development team is able to launch new treatments for the life-threatening diseases in a quick time.
What’s New At The Latest Website:
Witnessing its customers talking about various products and services and praising them always gives joy to any company. With the launch of the new website, Pharmacyte looks forward to sharing its growth with all the customers. It’s more focused, organized and easy to use than the previous ones. Management of the company is delighted to launch this new website at this time.
As per the reports, CEO Kenneth L. Waggoner has announced that the growth story of Pharmacyte is motivating and incredible to share with all the customers. The company will look to share its story, development of Cell-in-a-Box technology and other such developments with users from time to time through this website. It will not only prove to be an effective sharing medium, but also help the company establish a connection with all the users.